| Bioactivity | Glycolic acid oxidase inhibitor 1 is a glycolate oxidase inhibitor, extracted from patent EP0021228A1, in Table IV. | ||||||||||||
| Target | Glycolate oxidase | ||||||||||||
| In Vivo | Glycolic acid oxidase inhibitor 1 inhibits oxalate biosynthesis in isolated perfused rat liver. Glycolate oxidase inhibitors provide a specific approach to the prevention and treatment of calcium oxalate renal lithiasis[1]. | ||||||||||||
| Name | Glycolic acid oxidase inhibitor 1 | ||||||||||||
| CAS | 77529-42-1 | ||||||||||||
| Formula | C16H10BrNO3 | ||||||||||||
| Molar Mass | 344.16 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Cragoe Jr., Edward J, et al. 4-Substituted-3-hydroxy-3-pyrroline-2,5-dione compounds, process for their preparation and pharmaceutical compositions containing the same.EP0021228A1. |
Glycolic acid oxidase inhibitor 1
CAS: 77529-42-1 F: C16H10BrNO3 W: 344.16
Glycolic acid oxidase inhibitor 1 is a glycolate oxidase inhibitor, extracted from patent EP0021228A1, in Table IV.
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.